GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Peptron 087010.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

93,300

-4.11%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩5.63bn

FY2016FY2025

Net income

−₩13.82bn

FY2016FY2025

Free cash flow

−₩23.58bn

FY2016FY2025

Shareholders' equity

₩142.01bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩5.63bn₩3.15bn₩3.34bn₩5.81bn₩6.62bn₩3.12bn₩1.80bn₩3.86bn₩3.22bn₩3.13bn
Gross profit₩1.53bn₩1.11bn₩1.14bn₩3.32bn₩4.54bn₩1.14bn₩656.6m₩1.45bn₩1.22bn₩1.22bn
Research and development₩15.45bn₩12.14bn₩11.44bn₩13.37bn₩14.84bn₩14.18bn₩9.84bn₩6.07bn₩3.74bn₩2.77bn
Operating income−₩21.26bn−₩16.54bn−₩15.79bn−₩15.25bn−₩15.67bn−₩17.78bn−₩12.70bn−₩7.91bn−₩4.95bn−₩3.56bn
Net income−₩13.82bn−₩22.03bn−₩15.92bn−₩15.06bn−₩15.04bn−₩18.38bn−₩17.72bn−₩3.73bn−₩4.43bn−₩3.19bn
Diluted earnings per share-594.74-948.77-774.68-730.25-729.24-891.16-1,156.01-608.84-291.56-242.63

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩178.98bn₩168.89bn₩52.50bn₩68.27bn₩77.87bn₩117.70bn₩60.99bn₩71.76bn₩53.05bn₩57.90bn
Cash and short-term investments———₩17.24bn₩30.24bn₩70.60bn₩17.57bn₩31.05bn₩20.58bn₩48.30bn
Total liabilities₩36.97bn₩17.18bn₩16.37bn₩15.17bn₩15.59bn₩40.57bn₩32.90bn₩26.66bn₩4.10bn₩4.69bn
Debt₩25.59bn₩8.06bn₩9.13bn₩9.23bn₩9.16bn₩9.24bn₩29.16bn₩2.00bn₩2.00bn₩2.00bn
Shareholders' equity₩142.01bn₩151.71bn₩36.13bn₩53.11bn₩62.28bn₩77.13bn₩28.09bn₩45.10bn₩48.95bn₩53.21bn
Shares outstanding23m23m21m21m21m21m15m6m15m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−₩20.59bn−₩12.77bn−₩10.97bn−₩11.72bn−₩10.61bn−₩13.55bn−₩9.60bn−₩4.18bn−₩5.63bn−₩2.73bn
Capital spending−₩3.00bn−₩1.41bn−₩868.5m−₩1.72bn−₩698.6m−₩3.10bn−₩5.01bn−₩10.14bn−₩21.85bn−₩2.98bn
Free cash flow−₩23.58bn−₩14.18bn−₩11.84bn−₩13.44bn−₩11.31bn−₩16.65bn−₩14.61bn−₩14.32bn−₩27.47bn−₩5.71bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩1.45bn₩1.97bn₩987.3m₩1.60bn₩1.43bn₩1.62bn₩1.54bn₩588.3m
Gross profit−₩534.9m₩578.1m−₩1.29bn₩976.9m₩815.9m₩1.03bn₩1.41bn₩142.5m
Operating income−₩7.95bn−₩5.78bn−₩5.69bn−₩6.24bn−₩4.98bn−₩4.35bn−₩3.52bn−₩4.76bn
Net income−₩7.71bn−₩6.11bn−₩4.68bn−₩2.02bn−₩3.80bn−₩3.32bn−₩5.05bn−₩4.77bn
Diluted earnings per share-331.84-263.08-201.35-87.09-163.53-143.03-217.26-231.66
Cash from operations−₩3.63bn−₩4.42bn−₩4.91bn−₩7.30bn−₩3.90bn−₩4.48bn−₩12.77bn−₩10.33bn
Capital spending−₩775.0m−₩6.67bn−₩1.61bn−₩521.0m−₩766.0m−₩98.0m−₩1.41bn−₩1.50bn
Free cash flow−₩4.40bn−₩11.09bn−₩6.52bn−₩7.82bn−₩4.66bn−₩4.57bn−₩14.18bn−₩11.83bn
Total assets₩167.98bn₩174.46bn₩178.98bn₩183.74bn₩161.95bn₩164.85bn₩168.89bn₩40.58bn
Cash and short-term investments—————₩115.53bn—₩5.27bn
Debt₩24.79bn₩26.19bn₩25.59bn₩26.58bn₩8.06bn₩9.11bn₩8.06bn₩12.66bn
Shareholders' equity₩129.48bn₩135.97bn₩142.01bn₩146.33bn₩143.98bn₩148.39bn₩151.71bn₩20.71bn

Financial ratios

Data as of 26 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin27.2%35.1%34.1%57.1%68.6%36.4%———
Operating margin-377.3%-524.6%-472.4%-262.2%-236.6%-569.7%———
Net margin-245.3%-699.0%-476.4%-259.1%-227.1%-589.0%———
Return on equity-9.7%-14.5%-44.1%-28.4%-24.2%-23.8%———
Return on assets-7.7%-13.0%-30.3%-22.1%-19.3%-15.6%———
Free cash flow yield——————-0.2%0.5%0.6%
Revenue growth78.8%-5.7%-42.5%-12.2%112.3%73.3%———
Earnings growth-37.3%38.4%5.7%0.1%-18.2%3.7%———
Current ratio16.45x24.81x1.16x2.16x4.95x2.52x———
Debt to equity0.18x0.05x0.12x0.06x0.10x0.12x———
Equity ratio79.3%89.8%68.8%77.8%80.0%65.5%———
Interest coverage-16.09x-34.97x-39.86x-54.52x-425.47x————
R&D as a share of sales274.1%385.0%342.4%229.9%224.0%454.4%———
Buybacks as a share of market value——————-150.4%59.7%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-1.0%12.5%7.2%
Operating income11.7%3.6%22.3%
Net income-2.8%-5.5%17.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin30.0%39.6%46.2%42.9%
Operating margin-430.1%-383.6%-369.4%-315.8%
Net margin-408.1%-372.5%-362.1%-310.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-427.1-107.3-50.4-10.2-14.8-17.8-15.6-37.0-104.3-74.4
Price to sales——240.026.333.5105.1153.435.6143.775.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 950-for-921 split · 8 Oct 2024
  • 2-for-1 split · 25 Jul 2018

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.